908 Devices (NASDAQ:MASS) Updates FY 2021 Earnings Guidance

908 Devices (NASDAQ:MASS) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided earnings per share guidance of – for the period. The company issued revenue guidance of $38 million-$40 million, compared to the consensus revenue estimate of $39.34 million.

Shares of 908 Devices stock traded up $0.08 on Friday, reaching $36.83. 692,008 shares of the company traded hands, compared to its average volume of 263,896. 908 Devices has a 52 week low of $33.71 and a 52 week high of $79.60. The business has a 50 day moving average of $50.23.

908 Devices (NASDAQ:MASS) last released its earnings results on Monday, March 29th. The company reported ($1.48) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($1.32). The firm had revenue of $5.72 million for the quarter, compared to analysts’ expectations of $5.28 million. As a group, research analysts expect that 908 Devices will post -0.4 earnings per share for the current fiscal year.

Separately, SVB Leerink reduced their target price on shares of 908 Devices from $70.00 to $65.00 and set an outperform rating for the company in a research report on Friday.

908 Devices Company Profile

908 Devices Inc develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

See Also: Are Wall Street analysts’ stock ratings worth following?

Earnings History and Estimates for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.